Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer
2 المشاهدات
administrator
09/30/23
Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.
أظهر المزيد
تعليقات الفيسبوك
لم يتم العثور على تعليقات